Treatment Registry
TR-0419 ActiveRecorded September 2, 2026Last verified September 3, 2026

Brand tirzepatide

Sold by Maven Clinic · Injection, vial · every brand tirzepatide record

What you actually pay

Per month

$449

Medication · Zepbound Vial, self-pay$299
Required membership$150

Added from the figures recorded below.

Price

TermPer monthCharged today
Zepbound Vial, self-pay

Zepbound® Vial Tirzepatide injectable, self-administered from a vial, targeting two appetite-regulating hormones for lasting weight loss $299/mo self-pay | Starting from $25/mo with insurance

source, read September 2, 2026

Per month$299Charged today$299
Zepbound Vial, with insurance (starting from)

$299/mo self-pay | Starting from $25/mo with insurance

source, read September 2, 2026

Per month$25Charged today$25
Visit Maven Clinic

We earn nothing from this link. Maven Clinic has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$299
  2. September 3, 2026$299
  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberBoth
MembershipRequired. $150 per month. “$150 / month after Medication costs separate—as low as $149/mo for self-pay”
Consult feeNone. “Two free specialist consultations (nutrition & strength training)”

Not yet checked: pharmacy, states and cancellation.

Recorded from mavenclinic.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0419
Readings
2

Related records

What else Maven Clinic sells

All Maven Clinic programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Maven Clinic brand tirzepatide (TR-0419). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0419

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.